The Midwest faces some of the highest obesity rates in the country, and Wheaton is no exception. With Illinois reporting 33.1% obesity prevalence and 10.9% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to Wheaton residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Wheaton is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Wheaton, IL. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Wheaton, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Illinois residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Wheaton address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
Wheaton is home to a large and vibrant Hispanic community, and Weight Method is committed to providing culturally competent care when prescribing Tirzepatide. Our bilingual providers understand the dietary traditions, family dynamics, and health concerns that are common in Hispanic households — and they deliver consultations in English or Spanish. Tirzepatide does not require abandoning cultural foodways; it works by reducing appetite so you naturally eat smaller portions of the foods you love.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Illinois and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.